32,000 pounds of cooked chicken sausage being recalled
Federal officials say a Massachusetts company is recalling more than 32,000 pounds of cooked chicken sausage product due to misbranding and undeclared allergens.
US clears breakthrough gene therapy for childhood leukemia
The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells to seek and destroy childhood leukemia.
Home Depot settles charges that it sold recalled products
Home Depot has agreed to pay the U.S. government $5.7 million to settle charges that it sold recalled washing machines, fire extinguishers and other faulty products.
Harvey victim takes action against looters
Victim evacuated home due to Hurricane
Harvey could financially hurt already strained Houston hospitals
Structural improvements over the last decade to Houston hospitals have helped them so far to avoid devastation like Hurricane Katrina in New Orleans in 2005, but the pounding it is receiving from Tropical Storm Harvey is expected to financially hobble many already strained Texas medical centers.
Tainted eggs: Dutch court rules 2 suspects to remain jailed
A Dutch court says that two directors of a poultry farm cleaning company at the center of a Europe-wide tainted food scare must remain in custody for a further 30 days while investigations into their alleged involvement in the scandal continue.
Harvey's medical threat
Harvey's impact on hospitals
Business Highlights
___ Most Harvey flood victims on hook to pay for home repairs NEW YORK (AP) — Insurance experts say only a small percentage of homeowners in Harvey's path of destruction have flood insurance.
Medicare to foot the bill for treadmill therapy for leg pain
Three times a week, Rita Driscoll steps onto a treadmill at a Minnesota hospital under the eye of a rehab therapist.
New drug reduces heart attacks, but is that enough?
So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it?
Asian stocks fall, rattled by North Korean missile launch
U.S. stocks are rising Monday morning, with health care companies making some of the largest gains after biotechnology company Gilead Sciences agreed to buy cancer drug maker Kite Pharma for $11.9 billion.
Kite Pharma and Valero rise while Expedia and Travelers sink
Stocks that moved substantially or traded heavily Monday: Expedia Inc., down $6.73 to $142.53
Markets Right Now: Stocks finish mixed in quiet trading
The latest on developments in financial markets (All times local): 9:35 a.m.
Gilead to pay $11.9B for cancer treatment developer Kite
Gilead Sciences is buying Kite Pharma for $11.9 billion, giving the biotechnology company a broader portfolio of potential cell therapies for cancer.
Gilead to buy Kite Pharma for roughly $11B in cash
Gilead Sciences has agreed to pay about $11 billion for Kite Pharma and its promising new technology for harnessing the body's immune system to fight cancer, according to people familiar with the matter.
Recalls this week: boots, off-highway vehicles
More than 30,000 Dr. Martens boosts are being recalled because wearers can be exposed to the chemical benzidine, which is carcinogenic.
Business Highlights
___ Walmart joins forces with Google on voice-activated shopping NEW YORK (AP) — Walmart is diving into voice-activated shopping.
Former Dutch government minister to lead tainted egg probe
The Dutch government has appointed a former justice minister to lead an investigation into the illegal use of a pesticide to treat laying hens for lice infestations, which sparked a food scare in Europe and beyond and led to the destruction of millions of eggs.
How to tell if the price is right on your next prescription
Filling a prescription is no longer the simple errand you run after a doctor visit.
Insurers seek health care policy clarity as critical deadlines loom
Insurers face two critical deadlines in September, by which time it appears increasingly unlikely they will have clarity on a number of key issues, including whether the federal government will continue funding key ObamaCare subsidies.











